Use of GP73 in the diagnosis of non-alcoholic steatohepatitis and the staging of hepatic fibrosis

OBJECTIVE: To evaluate the utility of Golgi protein 73 (GP73) in the diagnosis of non-alcoholic steatohepatitis (NASH) and hepatic fibrosis (HF) staging. METHODS: Ninety-one patients with non-alcoholic fatty liver disease (NAFLD) were allocated to NAFL (n = 46) and NASH (n = 45) groups according to...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yadi, Yang, Yan, Li, Yufang, Zhang, Ping, Ge, Gaiying, Jin, Jing, Du, Ting, Ma, Maiyan, Na, Li, Ding, Lu, Sheng, Huiping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Retrospective Clinical Research Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8593324/
https://www.ncbi.nlm.nih.gov/pubmed/34772312
http://dx.doi.org/10.1177/03000605211055378

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8593324/
https://www.ncbi.nlm.nih.gov/pubmed/34772312
http://dx.doi.org/10.1177/03000605211055378

Ejemplares similares